Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report January – March 2021

Impressive Q1 performance across all product segments · Double-digit sales and operating profit growth across all product segments in local currencies. · For the Smokefree product segment, continued momentum for ZYN drove strong US performance and in Scandinavia good underlying development was further enhanced by timing effects on shipments and COVID-19 related channel mix effects. · For Cigars, record volumes, sales and operating profit on the back of strong category growth and improved price mix. · No major operational COVID-19 related disruptions and COVID-19 related effects

Record breaking season 20-21 at Pyhä Ski resort

Heading into the coming season with the biggest investments in the resort's historyPyhä ski resort has seen an increase in ski days of 25% compared to the previous full season of 2018-2019, and almost 50% growth compared to last season, which ended prematurely due to COVID-19 restrictions. The positive development in visitor amounts has created a need for additional accommodation capacity at Pyhä. The Kultakero project – an investment of 10 million euros – will increase Pyhä ski resort’s total investments to a record high of over 15 million euros over the coming season. Pyhä ski

AZN: First quarter 2021 results

AstraZeneca PLC 30 April 2021 07:00 BST   First quarter 2021 results Robust performance supports continued investment for long-term sustainable growth   AstraZeneca delivered robust revenue growth of 15% (11% at CER[1]) in the quarter to $7,320m; excluding the contribution from the pandemic COVID-19 vaccine, revenue growth increased by 11% (7% at CER) to $7,045m. The overall results in the quarter further increased the Company's profitability and cash generation, while the pipeline demonstrated encouraging progress; the Company reiterates full-year 2021 guidance. Pascal

Exel Composites' Business Review Q1 2021: Strong order intake and revenue in Q1 2021

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      30 APRIL 2021 at 09:00 EETQ1 2021 in brief  · Order intake increased by 21.7% to EUR 42.0 million (Q1 2020: 34.5). · Revenue increased by 11.3% to EUR 31.0 million (27.8).  · Operating profit increased to EUR 2.4 million (1.9), which is 7.8% of revenue (6.7). · Adjusted operating profit increased to EUR 2.5 million (2.1), which is 7.9% of revenue (7.5).  · Earnings per share amounted to EUR 0.17 (0.06).     Guidance for the full year 2021 Exel Composites expects revenue and adjusted operating profit in 2021 to

CELLINK announces an increase in number of shares and votes

The number of shares and votes in CELLINK AB (publ) have increased as a result of a directed new issue of 284,176 shares of series B which was carried out as a part of the financing for the acquisition of MatTek Corporation. The Board of Directors resolved on an issue in kind on March 22, 2021 in accordance with the authorization from the Extraordinary General Meeting held on December 17, 2020. Through the above mentioned event, which the Swedish Companies Registration Office registered during April, the number of shares and votes in CELLINK increased by a total of 284,176. As of

Conversion of shares

According to SCA’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.In April, at the request of shareholders 75 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,283,630,862. The total number of registered shares in the company amounts to 702,342,489 of which 64,587,597 are Class A shares

Number of shares and votes in Oncopeptides

Stockholm — April 30, 2021 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the number of shares and votes in Oncopeptides has changed due to the directed issue of 7,000,000 shares, which was carried out in March, and registered by the Swedish Companies Registration Office in April 2021.The directed share issue entails a dilution of approximately 9.3 percent of the number of shares and votes in the company. Through the issue, the number of outstanding shares and votes has increased by 7,000,000 from 68,084,855 to 75,084,855. The share capital has increased by approximately

Serneke launches framework for green bonds

Serneke has developed a new framework that makes it possible to issue green bonds. The purpose is to finance construction projects focusing on sustainability.“For the company, this is another step on the way to an increased focus on sustainability and it also demonstrates that we are involved and actively contribute to the development in the area”, says Anders Düring, CFO of Serneke Group. The proceeds from the future green bonds will be used to finance projects that have been assessed by Serneke in accordance with the green framework. Projects include both housing and commercial

SynAct Pharma to participate at Kempen’s virtual Life Sciences Conference

SynAct Pharma AB ("SynAct") today announced that the company will participate at the virtual meeting Kempen Life Sciences Conference - 2021 Thematic Virtual Series, on May 5.The presentation will be available via SynAct’s website: www.synactpharma.com. More information about the event is available at the organizer’s website: https://www.kempen.com/en/securities/events/life-sciences-conference The information was submitted, through the agency of the contact persons below, for publication on April 30, 2021.

Interim Report Q1 2021

· SCA decided in September 2020 to discontinue its publication paper operations in line with the communicated strategy for profitable growth. During the quarter, SCA closed the three remaining publication paper machines at the Ortviken site. · Measures continue to be taken to avoid the spread of Covid-19. The pandemic has not had any significant effects on production. JANUARY  – MARCH, 2021(compared with January – March 2020) · Net sales amounted to SEK 4,172m (4,793). The lower sales level was related to the discontinued publication paper operations and the divestment of Wood

Increased number of shares and votes in Addnode Group

The number of shares and votes in Addnode Group AB (publ) has increased as a result of a new share issue of B shares resolved upon by the Board of Directors on April 1, 2021. Through the new share issue the number of B shares in the company increased by 204,802 and the votes increased by 204,802. As of the last trading day in April 2021, there were in total 33,632,058 shares in Addnode Group, divided into 987,174 A shares and 32,644,884 B shares, and 42,516,624 votes. This information is information that Addnode Group AB (publ) is required to publish pursuant to the Financial Instruments

2020 Annual Report and Sustainability Report

2020: Another Record Year for Angler Gaming plc: All-Time-High in Revenue, EBIT, Net ProfitAll figures are compared to 1 January - 31 December 2019 · Revenues increased by 52.45% to €43,487,631 (€28,526,661) · EBIT increased by 110.73% to €14,119,681 (€6,700,271) · EBIT margin of 32.47% (23.49%), an increase of 38.23% · Net Profit increased by 89.54% to €11,564,819 (€6,101,572) · Customer deposits increased by 28.19% to €92,674,661 (€72,292,951) · 40.03% increase in newly registered customers to 253,293 (180,547) · 117,634 new depositing customers (78,934), increase

First day of trading in Nilar shares on Nasdaq First North Premier Growth Market

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE LAW. Nilar International AB (publ) (“Nilar” or the “Company”), an innovative developer of batteries and electrical energy storage systems for stationary applications, today announces the outcome of the Offering of the

New segment reporting supporting our strategy – restated historical financial information

Scandi Standard AB (publ), the leading chicken provider in the Nordic region and Ireland, implements a new segment reporting with the two reportable segments Ready-to-cook and Ready-to eat. The new segment reporting is effective as of 1 January, 2021 and will be reported for the first time in the interim report for the first quarter 2021, published on 7[ ]May, 2021. In addition, a new definition of items affecting comparability with stricter classification has been adopted. To facilitate comparability with historical periods, Scandi Standard is today releasing restated historical financial

YIT’s Interim report January—March 2021

YIT Corporation  Stock Exchange Release  30 April 2021 at 9.00 a.m.YIT’s Interim report January—March 2021 Group’s adjusted operating profit improved to EUR 21 million. Gearing at target level. · YIT’s adjusted operating profit improved to EUR 21 million (8). · Solid performance in the housing segments continued. · Result stabilised in the Business premises segment. · Operating cash flow after investments was strong at EUR 70 million (-48) supported by strong apartment sales and decreased capital employed in Housing Finland and CEE. · Net interest-bearing debt decreased

Orkla wants to be one of the foremost players in alternative proteins in Europe

Orkla’s goal is to become one of Europe’s leading competitors in the alternative proteins space before 2030.  That is why the Group is now establishing Orkla Alternative Proteins (OAP) as a separate business unit.“We are just at the beginning of a massive shift towards alternative protein sources. For Orkla, alternative proteins is an important priority area that offers major growth opportunities.  Our goal is to reach out to everyone with plant-based food, and to ensure that people can choose these products without having to compromise on taste or consistency.  We intend to make it easier

Change in the YIT Management Team

YIT Corporation  Stock Exchange Release  30 April 2021 at 8:45 a.m.Change in the YIT Management Team YIT Corporation's Board of Directors has appointed Ilkka Tomperi (45, Ph.D., Finance) as Executive Vice President of Partnership Properties segment and a member of the Group Management Team. He shall take over his position at the beginning of August 2021. Ilkka Tomperi is currently working as an Investment Director, Head of Real Estate at Varma Mutual Pension Insurance Company. Prior to Varma, he has worked for CapMan, Franklin Templeton Investments and the State Pension Fund of

Kid ASA - Invitation to presentation of First quarter 2021 results

Lier, 30 April 2021: Kid ASA will release its first quarter 2021 results on Wednesday 12 May 2021. The quarterly report and presentation material will be available on http://investor.kid.no and http://newsweb.no from 07:30 CET.The results will be presented at 09:00 CET by CEO Anders Fjeld and CFO Eystein Lund at ABG Sundal Colliers’ Office in Oslo. Consequent on the Covid-19 pandemic there will only be the possibility to attend digitally by the following link: Link to KID ASA Q1 Presentation 

Photocure publishes its 2020 ESG Report

Press release – Oslo, Norway, April 30, 2021: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of its sustainability (ESG) report for 2020, renewing its commitment to transparency, corporate governance principles, sustainability and business ethics.As a result of this commitment, Photocure has also recently become a signatory of the United Nations Global Compact.Reflecting on ESG matters in 2020, Dan Schneider, President and CEO of Photocure said: “At Photocure, our mission is to deliver transformative solutions to improve the lives of bladder cancer

Improved result for Lindex for first quarter 2021

Today, Lindex presents its interim report and shows an improved result for the first quarter of 2021. A continued rapid digital growth, improved margins and cost saving actions contributed to the strengthened result. Lindex’s operating result* for January-March 2021 increased by 33 MSEK and amounted to -146 MSEK (-179 MSEK 2020). Lindex’s adjusted operating result increased by 88 MSEK and amounted to -91 MSEK (-179 MSEK 2020) The strengthened result is an effect of the fashion company’s rapid digital growth, improved margins and implemented cost saving actions.  “Despite a

Stockmann Group’s Interim Management Statement, 1 January – 31 March 2021

Improved adjusted result despite strict COVID-19 restrictionsSTOCKMANN plc, Interim report, 30.4.2021 at 8.00 EET January–March 2021:- Consolidated revenue was EUR 155.7 million (168.4), down 7.1% in comparable currency rates.- Gross margin was 56.3% (54.2).- Operating result was EUR -27.7 million (-27.8).- The adjusted operating result was EUR -21.1 million (-26.7).- Earnings per share were EUR -0.41 (-0.52).- Adjusted earnings per share were EUR -0.32 (-0.50). Guidance for 2021:The prolonged COVID-19 pandemic gives rise to a lack of clarity in Stockmann’s business

There are no items matching the current filter
There are no more items matching the current filter
Back to top